Only RAD51B and XRCC3 disclosed statistically significant differences between tumor and gynecomastia tissues, with higher methylation levels observed in gynecomastia tissue samples (Table 3, Figure 1). The gene discussed is RAD51B; the disease is Gynecomastia.